Professor, Medicine, George Washington U Sch of Med
Infectious Disease
Dr. Lawrence R. Deyton, MD
|
|
Give Review
Lawrence R. Deyton practices Infectious Disease. He graduated from George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care Lawrence Deyton is also published. He has 33 publications published. The lastest publication: "Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.'
Publications
- Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its f...
- FDA tobacco product regulations: a powerful tool for tobacco control.
- A new regulatory challenge: youth and tobacco.
- Pharmacokinetics and tolerability of oseltamivir combined with probenecid.
- Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDS.
- CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.
- AIDS-related malignant lymphoma: results of prospective treatment trials.
- Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.
- Clinical programs for clinical research on AIDS: description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of Toxoplasma gondii ...
- Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
- Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi''s sarcoma.
- Digital necrosis and disseminated Pneumocystis carinii infection after aerosolized pentamidine prophylaxis.
- Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)
- Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial.
- CD4+ T lymphocyte counts and patterns of mortality among patients infected with human immunodeficiency virus who were enrolled in community programs for clinical resea...
- Importance of surrogate markers in evaluation of antiviral therapy for HIV infection.
- Response of CD4 lymphocytes and clinical consequences of treatment using ddI or ddC in patients with advanced HIV infection.
- HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
- The Immunology Case Registry.
- Quality Enhancement Research Initiative for human immunodeficiency virus/acquired immunodeficiency syndrome: framework and plan. HIV-QUERI Executive Committee.
- Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Inv...
- Sex differences in HIV-1 viral load and progression to AIDS.
- Experience with a cross-study endpoint review committee for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS.
- A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or...
- Community-based HIV trials are rigorous, says NIH.
- Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma.
- Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.
- Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).
- War, its aftermath, and U.S. health policy: toward a comprehensive health program for America's military personnel, veterans, and their families.
- Community planning for pandemic influenza: lessons from the VA health care system.
- Tobacco product regulation--a public health approach.
- Results of antiretroviral treatment interruption and intensification in advanced multi-drug resistant HIV infection from the OPTIMA trial.
Schools
George Washington University School of Medicine And Health Sciences
Doctors Specialties
- Internal Medicine
- Infectious Disease
Accepted Insurances
- Aetna
- Cigna
- Medicare MCR
- Tricare
- United Healthcare
Education
-
National Institutes of Health Clinical Center -
University of Southern California - LAC+USC Medical Center -
George Washington University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Itzhak Brook, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Gayle P. Balba, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael V. Defazio, MD |
|
|
Dr. Walter Y. Goo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Misbah Zaheer, MD |
|
|
Dr. Adrien J. Mazer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenny E. Blau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Che M. Harris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jhansi L. Gajjala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bindhu Anand, MD |
|
|
Dr. Pallavi Belur, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John Whyte, MD |